10/30/2026

Ad-hoc: Statement by the Executive Board of Evonik Industries AG, October 30, 2026

The Executive Board of Evonik Industries AG has carefully reviewed the letter from BASF SE dated October 22, 2026, expressing its interest in making a voluntary public takeover offer. Based on the information available, the Executive Board has decided not to enter into negotiations with BASF SE. The Executive Board remains focused on its strategic direction and further development of Evonik as an independent company.

At the same time, the Executive Board has expressed its willingness to engage in a purely informational and confidential exchange with BASF SE in order to explain Evonik Industries AG’s position and to give BASF SE the opportunity to outline its rationale and the key considerations underlying its interest.

Contacts

Christoph Finke

Senior Vice President Investor Relations

Spoken languages: german, english

+49 174 9931647 Send email

Downloads

Evonik: Leading beyond chemistry

Evonik goes beyond the boundaries of chemistry with its combination of innovative strength and leading technological expertise. The global chemical company, headquartered in Essen, Germany, is active in more than 100 countries and generated sales of €14.1 billion and earnings (adjusted EBITDA) of €1.9 billion in 2025. The common motivation of the approximately 31,000 employees: to provide customers with a decisive competitive advantage with tailor-made products and solutions as a superforce for industry, thereby improving people's lives. In all markets. Every day.

Disclaimer

In so far as forecasts or expectations are expressed in this release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.